AR035778A1 - Uso de 2-amino-1-(4-hidroxi-2-metanosulfonamidofenil)etanol para tratar la incontinencia urinaria - Google Patents
Uso de 2-amino-1-(4-hidroxi-2-metanosulfonamidofenil)etanol para tratar la incontinencia urinariaInfo
- Publication number
- AR035778A1 AR035778A1 ARP020100352A ARP020100352A AR035778A1 AR 035778 A1 AR035778 A1 AR 035778A1 AR P020100352 A ARP020100352 A AR P020100352A AR P020100352 A ARP020100352 A AR P020100352A AR 035778 A1 AR035778 A1 AR 035778A1
- Authority
- AR
- Argentina
- Prior art keywords
- ethanol
- amino
- urinary incontinence
- methanosulphonamidephenyl
- hydroxi
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Suspension/Interruption
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/31—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms
- C07C311/35—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Medicamentos que contienen 2-amino-1(4-hidroxi-2-metanosulfonamidofenil)etanol, uno de sus dos isómeros ópticos y/o sus sales farmacológicamente aceptables, en particular para tratar la incontinencia urinaria.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10104369A DE10104369A1 (de) | 2001-02-01 | 2001-02-01 | Verwendung von 2-Amino-(4-hydroxy-2-methansulfonamidophenyl)ethanol zur Behandlung der Harninkontinenz |
Publications (1)
Publication Number | Publication Date |
---|---|
AR035778A1 true AR035778A1 (es) | 2004-07-14 |
Family
ID=7672382
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP020100352A Suspension/Interruption AR035778A1 (es) | 2001-02-01 | 2002-02-01 | Uso de 2-amino-1-(4-hidroxi-2-metanosulfonamidofenil)etanol para tratar la incontinencia urinaria |
Country Status (26)
Country | Link |
---|---|
EP (1) | EP1363614B1 (es) |
JP (1) | JP2004517158A (es) |
KR (1) | KR20030075173A (es) |
CN (1) | CN1489459A (es) |
AR (1) | AR035778A1 (es) |
AT (1) | ATE293966T1 (es) |
BG (1) | BG108033A (es) |
BR (1) | BR0206854A (es) |
CA (1) | CA2434565A1 (es) |
CZ (1) | CZ20032097A3 (es) |
DE (2) | DE10104369A1 (es) |
DK (1) | DK1363614T3 (es) |
EA (1) | EA200300789A1 (es) |
EC (1) | ECSP034684A (es) |
EE (1) | EE200300357A (es) |
ES (1) | ES2240708T3 (es) |
HU (1) | HUP0302752A2 (es) |
IL (1) | IL156730A0 (es) |
MX (1) | MXPA03006816A (es) |
NO (1) | NO20033428L (es) |
PL (1) | PL361731A1 (es) |
PT (1) | PT1363614E (es) |
SK (1) | SK9772003A3 (es) |
UY (1) | UY27145A1 (es) |
WO (1) | WO2002060421A2 (es) |
ZA (1) | ZA200305201B (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10352132A1 (de) * | 2003-11-04 | 2005-06-09 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmazeutische Zusammensetzung aus einem Beta-3-Adrenozeptor-Agonisten und einem Alpha Agonisten |
AU2014309012B2 (en) * | 2013-08-19 | 2019-03-14 | Taris Biomedical Llc | Multi-unit drug delivery devices and methods |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US341584A (en) * | 1886-05-11 | Device foe | ||
FR148F (es) * | 1962-01-24 | |||
ATE128459T1 (de) * | 1990-02-07 | 1995-10-15 | Nippon Shinyaku Co Ltd | Sulfonanilidderivat und arzneimittel. |
DE19514579A1 (de) * | 1995-04-20 | 1996-10-24 | Boehringer Ingelheim Kg | Verwendung von alpha¶1¶¶L¶-Agonisten zur Behandlung der Harninkontinenz |
AU6003596A (en) * | 1995-06-02 | 1996-12-18 | Synaptic Pharmaceutical Corporation | The use of alpha-1c-selective adrenoceptor agonists for the treatment of urinary incontinence |
FR2737494B1 (fr) * | 1995-08-04 | 1997-08-29 | Synthelabo | Derives de benzenesulfonamide, leur preparation et leur application en therapeutique |
WO2000010557A1 (fr) * | 1998-08-25 | 2000-03-02 | Nippon Shinyaku Co.,Ltd. | Preparations solides stabilisees |
-
2001
- 2001-02-01 DE DE10104369A patent/DE10104369A1/de not_active Withdrawn
-
2002
- 2002-01-15 CN CNA02804407XA patent/CN1489459A/zh active Pending
- 2002-01-15 WO PCT/EP2002/000311 patent/WO2002060421A2/en active IP Right Grant
- 2002-01-15 EP EP02710006A patent/EP1363614B1/en not_active Expired - Lifetime
- 2002-01-15 DK DK02710006T patent/DK1363614T3/da active
- 2002-01-15 DE DE60203882T patent/DE60203882T2/de not_active Expired - Fee Related
- 2002-01-15 KR KR10-2003-7010204A patent/KR20030075173A/ko not_active Application Discontinuation
- 2002-01-15 CA CA002434565A patent/CA2434565A1/en not_active Abandoned
- 2002-01-15 MX MXPA03006816A patent/MXPA03006816A/es unknown
- 2002-01-15 PL PL02361731A patent/PL361731A1/xx not_active Application Discontinuation
- 2002-01-15 CZ CZ20032097A patent/CZ20032097A3/cs unknown
- 2002-01-15 EE EEP200300357A patent/EE200300357A/xx unknown
- 2002-01-15 SK SK977-2003A patent/SK9772003A3/sk unknown
- 2002-01-15 HU HU0302752A patent/HUP0302752A2/hu unknown
- 2002-01-15 EA EA200300789A patent/EA200300789A1/ru unknown
- 2002-01-15 JP JP2002560614A patent/JP2004517158A/ja active Pending
- 2002-01-15 ES ES02710006T patent/ES2240708T3/es not_active Expired - Lifetime
- 2002-01-15 BR BR0206854-0A patent/BR0206854A/pt active Pending
- 2002-01-15 IL IL15673002A patent/IL156730A0/xx unknown
- 2002-01-15 PT PT02710006T patent/PT1363614E/pt unknown
- 2002-01-15 AT AT02710006T patent/ATE293966T1/de not_active IP Right Cessation
- 2002-01-30 UY UY27145A patent/UY27145A1/es not_active Application Discontinuation
- 2002-02-01 AR ARP020100352A patent/AR035778A1/es not_active Suspension/Interruption
-
2003
- 2003-07-04 ZA ZA200305201A patent/ZA200305201B/en unknown
- 2003-07-04 EC EC2003004684A patent/ECSP034684A/es unknown
- 2003-07-28 BG BG108033A patent/BG108033A/xx active Pending
- 2003-07-31 NO NO20033428A patent/NO20033428L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
KR20030075173A (ko) | 2003-09-22 |
SK9772003A3 (sk) | 2005-03-04 |
WO2002060421A3 (en) | 2002-12-19 |
CN1489459A (zh) | 2004-04-14 |
HUP0302752A2 (hu) | 2003-11-28 |
DE10104369A1 (de) | 2002-08-08 |
EA200300789A1 (ru) | 2004-02-26 |
DE60203882D1 (de) | 2005-06-02 |
DE60203882T2 (de) | 2006-02-02 |
MXPA03006816A (es) | 2004-05-14 |
ES2240708T3 (es) | 2005-10-16 |
CA2434565A1 (en) | 2002-08-08 |
PL361731A1 (en) | 2004-10-04 |
PT1363614E (pt) | 2005-06-30 |
ZA200305201B (en) | 2004-05-17 |
JP2004517158A (ja) | 2004-06-10 |
EE200300357A (et) | 2003-10-15 |
NO20033428L (no) | 2003-09-30 |
BG108033A (en) | 2004-12-30 |
WO2002060421A2 (en) | 2002-08-08 |
CZ20032097A3 (cs) | 2003-12-17 |
DK1363614T3 (da) | 2005-05-30 |
EP1363614B1 (en) | 2005-04-27 |
UY27145A1 (es) | 2002-08-30 |
ATE293966T1 (de) | 2005-05-15 |
IL156730A0 (en) | 2004-02-08 |
EP1363614A2 (en) | 2003-11-26 |
ECSP034684A (es) | 2003-08-29 |
NO20033428D0 (no) | 2003-07-31 |
BR0206854A (pt) | 2004-01-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0314603A (pt) | Uso de inibidores da sìntese de citoquina para o tratamento de distúrbios de olhos secos | |
ECSP034774A (es) | Pirazolopirimmidinas como agentes terapeuticos | |
ECSP034773A (es) | Pirazolopirimmidinas como agentes terapeuticos | |
SV2002000520A (es) | Derivados de pirazol ref. pcs10927aajr/bb | |
HN2002000275A (es) | Derivados de 1,8 naftiridina y su uso para el tratamiento de diabetes y trastornos relacionados | |
NO20002121L (no) | Benzotiazol-protein-tyrosin-kinaseinhibitorer | |
BRPI0413363A (pt) | formas de dosagem fornecendo liberação controlada de inibidores de proteìna de transferência de ésteres de colesterila e liberação imediata de inibidores de hmg-coa redutase | |
BRPI0609711B8 (pt) | uso de uma solução aquosa com potencial redutivo oxidativo (orp) | |
BR0317715A (pt) | Composições e processos de uso de collajolie | |
HN2003000054A (es) | Formas de dosificacion farmaceutica de liberacion controlada de un inhibidor de la proteina de transferencia de ester de colesterilo (cetpi), a procedimientos de uso y a procedimientos de preparacion de las mismas. | |
UY27740A1 (es) | Nuevos compuestos | |
CR7583A (es) | Nueva sal formiato de o-desmetil venlafaxina | |
BR0309492A (pt) | Uso de pelo menos um álcool ramificado alcoxilado | |
ECSP045520A (es) | Metodos de tratamiento con inhibidores de la ptec y agentes antihipertensivos | |
HN2001000217A (es) | Nuevos tiadiazoles y oxadiazoles y su uso como inhibidores de fosfodiesterasa - 7 | |
CO4940466A1 (es) | Sales metanosulfonato de 5-(2-(4-(1,2-benzoisotiazol-3-il)- 1-piperazinil)etil)-6-cloro-1,3-dihidro-2h-indol-2-ona dihidratadas | |
PA8506301A1 (es) | Cristal de 4- carboxamino- 1,2,3,4,- tetrahidroquinolina 2-sustituida | |
PA8586801A1 (es) | Inhibidores de hiv-integrasa, composiciones farmaceuticas y metodos para su uso | |
BR0317282A (pt) | Derivados de 3h-quinazolin-4-ona | |
WO2002000183A3 (en) | Use of egf-r protein tyrosine kinase inhibitors for preventing photoaging in human skin | |
BR0308762A (pt) | Formulação farmacêutica compreendendo melatonina | |
BR0211784A (pt) | Método para reduzir o crescimento capilar humano, uso de alfa-difluorometilornitina, e composição cosmética usada para a redução do crescimento capilar humano | |
AR035778A1 (es) | Uso de 2-amino-1-(4-hidroxi-2-metanosulfonamidofenil)etanol para tratar la incontinencia urinaria | |
HN1999000101A (es) | Inhibidores de las fkbp. | |
BR0115301A (pt) | Uso de um inibidor seletivo da recaptação de norepinefrina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |